欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2343/003
药品名称Rivaroxaban Bluefish
活性成分
    • Rivaroxaban 20.0 mg
剂型Film-coated tablet
上市许可持有人Bluefish Pharmaceuticals AB (publ) P. O. Box 49013 100 28 Stockholm Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Norway (NO)
    • Poland (PL)
    • Germany (DE)
      Rivaroxaban Bluefish 20 mg Filmtabletten
许可日期2024/01/16
最近更新日期2025/02/13
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase